1. Home
  2. MTNB

as 07-15-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Founded: 2013 Country:
United States
United States
Employees: N/A City: BEDMINSTER
Market Cap: 39.9M IPO Year: N/A
Target Price: $3.00 AVG Volume (30 days): 777.8K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.12 EPS Growth: N/A
52 Week Low/High: $0.11 - $0.89 Next Earning Date: 08-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

MTNB Daily Stock ML Predictions

Share on Social Networks: